Substantial Disparities Seen in Cancer Cases, Deaths Among Men
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 12, 2024 -- There are substantial disparities in cancer cases and deaths among men, which are projected to widen by 2050, according to a study published online Aug. 12 in Cancer.
Habtamu Mellie Bizuayehu, Ph.D., from the University of Queensland in Brisbane, Australia, and colleagues analyzed 30 cancer types among men in 2022 using GLOBOCAN estimates for men in 185 countries/territories worldwide and estimated projections for 2050. By dividing age‐standardized mortality rates by incidence rates, mortality-to-incidence ratios (MIRs) were calculated.
The researchers found that a high MIR was seen among older men (aged 65 years and older), for rare cancer types, and in countries with a low Human Development Index (HDI; 61, 91, and 74 percent, respectively) in 2022. Cancer cases are projected to increase from 10.3 to 19 million between 2022 and 2050 (≥84 percent), while deaths are projected to increase from 5.4 to 10.5 million (≥93 percent), with a more than twofold increase among men aged 65 years and older and for low- and medium-HDI countries/territories (≥117 and ≥160 percent, respectively). Among working-age groups and very high-HDI countries/territories, cancer cases and deaths are projected to increase (≥39 and ≥50 percent, respectively).
"A national and international collaboration, as well as a coordinated multisectoral approach, are essential to improve current cancer outcomes and to reverse the anticipated rise in cancer burden by 2050," Bizuayehu said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
CRC as First of Multiple Primary Malignancies Tied to Better Outcomes Than CRC as Only Malignancy
THURSDAY, June 26, 2025 -- Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the first of multiple primary...
Two-Hour Observation Probably Safe for Most Children With Anaphylaxis
THURSDAY, June 26, 2025 -- For most children who present to an emergency department with an acute allergic reaction requiring epinephrine, a two-hour observation period is...
CT Perfusion and CT Angiography Not Useful as Standalone Tests for Establishing Death by Neurologic Criteria
THURDAY, June 26, 2025 -- Neither computed tomography (CT) perfusion nor CT angiography meet the prespecified validation threshold as an ancillary test for death by neurologic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.